Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 2.13 B775 M1.43 B2.75 B1.07 B1.09 B 6.35 B Non-Operating Income, Total 107 M113 M119 M99 M121 M97 M 436 M Interest expense, net of interest capitalized 301 M504 M488 M246 M524 M514 M 1.77 B Non-Operating Income, excl. Interest Expenses 107 M113 M-369 M-147 M-403 M-417 M -1.34 B Unusual income/expense —————— — Pretax income 1.94 B384 M1.06 B2.6 B671 M675 M 5.01 B Equity in earnings —————— — Taxes 448 M-14 M175 M682 M101 M114 M 1.07 B Non-controlling/minority interest —————— — After tax other income/expense -28 M-49 M-46 M-53 M-27 M— — Net income before discontinued operations 1.44 B343 M832 M1.85 B531 M534 M 3.75 B Discontinued operations —————— — Net income 1.44 B343 M832 M1.85 B531 M534 M 3.75 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 1.44 B343 M832 M1.85 B531 M534 M 3.75 B Basic earnings per share (Basic EPS) 3.730.892.164.81.381.39 9.73 Diluted earnings per share (Diluted EPS) 3.720.892.164.781.371.38 9.69 Average basic shares outstanding 385 M385 M385 M385 M385 M385 M — Diluted shares outstanding 386 M386 M386 M386 M387 M387 M — EBITDA 2.88 B1.6 B2.29 B3.56 B1.91 B— — EBIT 2.13 B775 M1.43 B2.75 B1.07 B1.09 B 6.35 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 742 M826 M862 M807 M834 M— —